These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30548972)

  • 21. Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis.
    Gansmo LB; Lie BA; Mæhlen MT; Vatten L; Romundstad P; Hveem K; Lønning PE; Knappskog S
    Gene; 2021 Aug; 793():145747. PubMed ID: 34077778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women.
    Kang S; Wang DJ; Li WS; Wang N; Zhou RM; Sun DL; Duan YN; Li SZ; Li XF; Li Y
    Int J Gynecol Cancer; 2009 May; 19(4):572-7. PubMed ID: 19509552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
    Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
    Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
    Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
    IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females.
    Choi JH; Lee J; Yang S; Lee EK; Hwangbo Y; Kim J
    Sci Rep; 2018 Oct; 8(1):15004. PubMed ID: 30301923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma.
    Song CM; Kwon TK; Park BL; Ji YB; Tae K
    Environ Mol Mutagen; 2015 Jan; 56(1):70-6. PubMed ID: 25196645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.
    Lesueur F; Corbex M; McKay JD; Lima J; Soares P; Griseri P; Burgess J; Ceccherini I; Landolfi S; Papotti M; Amorim A; Goldgar DE; Romeo G
    J Med Genet; 2002 Apr; 39(4):260-5. PubMed ID: 11950855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-nucleotide polymorphism (c.309T>G) in the
    Enokida Y; Shimizu K; Kakegawa S; Atsumi J; Takase Y; Miyamae Y; Nagashima T; Ohtaki Y; Kaira K; Sunaga N; Yanagitani N; Yoshino R; Tsunekawa K; Igai H; Kamiyoshihara M; Usui K; Lezhava A; Tomizawa Y; Ishikawa T; Murakami M; Hayashizaki Y; Takeyoshi I
    Biomed Rep; 2014 Sep; 2(5):719-724. PubMed ID: 25054017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 Variants and Acute Myeloid Leukemia Susceptibility, Risk Stratification Scores, and Clinical Features: An Exploratory Study.
    Tripon F; Iancu M; Trifa A; Crauciuc GA; Boglis A; Balla B; Cosma A; Dima D; Candea M; Lazar E; Jimbu L; Banescu C
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32492903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical analysis between trefoil factor 3 gene polymorphsims and susceptibility to papillary thyroid carcinoma].
    Pei D; Xue G; Wu JF; Wang DM; Qin XJ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 33(10):926-931. PubMed ID: 31623036
    [No Abstract]   [Full Text] [Related]  

  • 32. Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma.
    Liu Y; Li Z; Tang X; Li M; Shi F
    Recent Pat Anticancer Drug Discov; 2019; 14(3):268-279. PubMed ID: 31538903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.
    Hong Y; Miao X; Zhang X; Ding F; Luo A; Guo Y; Tan W; Liu Z; Lin D
    Cancer Res; 2005 Oct; 65(20):9582-7. PubMed ID: 16230424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ID genotype of MDM2 40 bp insertion/deletion polymorphism was associated with lower risk of SLE.
    Salimi S; Rezaei M; Mohammadpour-Gharehbagh A; Sajadian M; Sandoughi M
    Postgrad Med J; 2017 Dec; 93(1106):758-761. PubMed ID: 28676527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
    Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDM2 rs2279744 and TP53 rs1042522 polymorphisms associated with etoposide- and cisplatin-induced grade III/IV neutropenia in Chinese extensive-stage small-cell lung cancer patients.
    Wang X; Wang YZ; Ma KW; Chen X; Li W
    Oncol Res Treat; 2014; 37(4):176-80. PubMed ID: 24732641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The endothelin 1 and endothelin receptor A gene polymorphisms increase the risk of developing papillary thyroid cancer.
    Aydin AF; Vural P; Doğru-Abbasoğlu S; Çil E
    Mol Biol Rep; 2019 Feb; 46(1):199-205. PubMed ID: 30411193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese.
    Li H; Dai H; Li H; Li B; Shao Y
    Curr Mol Med; 2019; 19(6):443-451. PubMed ID: 31288714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.
    Alshatwi AA; Hasan TN; Shafi G; Alsaif MA; Al-Hazzani AA; Alsaif AA
    Fundam Clin Pharmacol; 2012 Jun; 26(3):438-43. PubMed ID: 21477265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population.
    Duffek M; Skerenova M; Halasova E; Sarlinova M; Dzian A; Repiska V; Dobrovodsky A; Mistuna D; Bernadic M; Matakova T
    Bratisl Lek Listy; 2022; 123(7):475-48. PubMed ID: 35907052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.